Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
About this item
Full title
Author / Creator
Eichenfield, Lawrence F. , Bieber, Thomas , Beck, Lisa A. , Simpson, Eric L. , Thaçi, Diamant , de Bruin-Weller, Marjolein , Deleuran, Mette , Silverberg, Jonathan I. , Ferrandiz, Carlos , Fölster-Holst, Regina , Chen, Zhen , Graham, Neil M. H. , Pirozzi, Gianluca , Akinlade, Bolanle , Yancopoulos, George D. and Ardeleanu, Marius
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Patients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections. Immunomodulators (e.g., anti-tumor necrosis factors, anti-interleukin [anti-IL]-23, anti-IL-17, Janus kinase inhibitors) increase risk of infections. Dupilumab (a monoclonal antibody blocking the sh...
Alternative Titles
Full title
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6533236
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6533236
Other Identifiers
ISSN
1175-0561,1179-1888
E-ISSN
1179-1888
DOI
10.1007/s40257-019-00445-7
